Reverba Global introduces ClinOps G.P.S.™, an operations platform of integrated technology solutions that provides companies sponsoring clinical trials with end-to-end trial readiness, governance, and ...
Certara has maintained its leadership in the multidisciplinary field of pharmacology and pharmacokinetics since the inaugural list. This year, the following Certara researchers appeared on ...
Franklin Street Advisors' purchase of Thermo Fisher Scientific is notable as the firm grew the stock's portfolio allocation ...
A rumor has circulated online since at least 2024 claiming that Japanese researchers have developed a drug that might help ...
Enterprise platform, queried through natural language, to help pharma, biotech, and investors make better decisions.
Psychiatric disorders affect over 20% of US adults, presenting complex challenges in diagnosis and treatment due to frequent ...
In an era where the biopharmaceutical landscape is rapidly evolving, a comprehensive approach to demonstrating and ...
Thermo Fisher will equip Dr. Park CDMO’s new facility with advanced bioreactors to scale viral vector manufacturing.
Pursuant to the terms of the transaction announced on July 20, 2025, ARCHIMED acquired all of the outstanding shares of ZimVie stock. ZimVie stockholders are entitled to receive $19.00 in cash for ...
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” third-quarter 2025 investor ...
ZimVie Inc. ("ZimVie"), a global life sciences leader in the dental implant market, today announced that ARCHIMED, an investment firm focused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback